Evidence map›Paper›PMID 41730819›Full record

ArticleBiochemical and biophysical research communications2026

Solution NMR reveals micelle-stabilized α-helical segments flanking the RIPK1 RHIM amyloid core.

Paula Polonio, Gustavo A Titaux-Delgado, Miguel Mompeán

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paula PolonioInstituto de Química Física Blas-Cabrera (IQF-CSIC), Madrid, Spain; Universidad Autónoma de Madrid, Escuela de Doctorado, Madrid, Spain.
Gustavo A Titaux-DelgadoInstituto de Química Física Blas-Cabrera (IQF-CSIC), Madrid, Spain.
Miguel MompeánInstituto de Química Física Blas-Cabrera (IQF-CSIC), Madrid, Spain. Electronic address: mmompean@iqf.csic.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Receptor Interacting Protein Kinase 1 (RIP1 or RIPK1) can transition from a monomeric state to amyloid assemblies during cell signaling via a conserved RIP homotypic interaction motif (RHIM). Through RHIM-RHIM interactions, RIPK1 forms both homomeric and heteromeric amyloids implicated in programmed cell death, but solution-state characterization of unassembled RIPK1 is hindered by rapid aggregation. Building on our recent RIPK1 fibril structure, we designed an aggregation-slowing mutant (N545D) and show that two segments within RIPK1's disordered domain display nascent helical propensity under near-physiological pH conditions. SDS micelles further stabilize these helices and enable measurements on the wild-type sequence. Notably, analogous conditions do not reveal comparable α-helical populations in RIPK3, despite a conserved RHIM sequence and amyloid structure endpoint.

Indexed as

AmyloidReceptor-Interacting Protein Serine-Threonine KinasesAmino Acid SequenceHumansMicellesNuclear Magnetic Resonance, BiomolecularProtein Conformation, alpha-HelicalProtein Structure, SecondaryAmyloidMicellesReceptor-Interacting Protein Serine-Threonine KinasesRIPK1 protein, human

Identifiers

PMID41730819
PMCPMC7618886

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.